Osaic Holdings
DNA icon

Osaic Holdings’s Ginkgo Bioworks DNA Stock Holding History

Osaic Holdings’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.7K Sell
4,110
-75
-2% -$627 ﹤0.01% 5625
2026
Q1 		$25.6K Sell
4,185
-1,143
-21% -$9.51K ﹤0.01% 5704
2025
Q4 		$44.2K Sell
5,328
-185
-3% -$1.99K ﹤0.01% 5317
2025
Q3 		$72.6K Buy
5,513
+296
+6% +$3.54K ﹤0.01% 5048
2025
Q2 		$58.7K Sell
5,217
-321
-6% -$2.49K ﹤0.01% 4935
2025
Q1 		$31.5K Buy
5,538
+990
+22% +$10.1K ﹤0.01% 5037
2024
Q4 		$44.6K Sell
4,548
-4,531
-50% -$38.8K ﹤0.01% 4792
2024
Q3 		$74K Sell
9,079
-445
-5% -$4.46K ﹤0.01% 4443
2024
Q2 		$126K Sell
9,524
-6,175
-39% -$184K ﹤0.01% 3945
2024
Q1 		$728K Buy
15,699
+330
+2% +$17.1K ﹤0.01% 2625
2023
Q4 		$1.04M Buy
15,369
+5,918
+63% +$362K ﹤0.01% 2470
2023
Q3 		$684K Buy
9,451
+1,978
+26% +$158K ﹤0.01% 2985
2023
Q2 		$557K Buy
7,473
+316
+4% +$18.7K ﹤0.01% 3058
2023
Q1 		$381K Buy
7,157
+2,702
+61% +$171K ﹤0.01% 3326
2022
Q4 		$300K Buy
4,455
+2,226
+100% +$205K ﹤0.01% 3516
2022
Q3 		$278K Buy
2,229
+200
+10% +$23.8K ﹤0.01% 3447
2022
Q2 		$194K Buy
2,029
+696
+52% +$84.9K ﹤0.01% 3825
2022
Q1 		$215K Buy
1,333
+65
+5% +$12.7K ﹤0.01% 3968
2021
Q4 		$423K Buy
1,268
+165
+15% +$78.4K ﹤0.01% 3224
2021
Q3 		$510K Buy
+1,103
New +$537K ﹤0.01% 3009

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Osaic Holdings's DNA Position: Q2 2026 in Review

Osaic Holdings reduced its Ginkgo Bioworks (DNA) stake by 1.8% in Q2 2026, selling an estimated $627 and leaving 4,110 shares worth $40.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5625.

Osaic Holdings first reported a position in DNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.04M in Q4 2023. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Osaic Holdings held 4,110 shares of Ginkgo Bioworks worth $40.7K as of Q2 2026.
  • Osaic Holdings sold 75 Ginkgo Bioworks shares in Q2 2026, an estimated $627.
  • Ginkgo Bioworks made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5625 holding.
  • Osaic Holdings first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 20 quarters since.
  • Osaic Holdings's Ginkgo Bioworks position peaked at $1.04M in Q4 2023.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.